Medication compliance and influencing factors of oral chemotherapy among patients with colorectal cancer: a longitudinal investigation

Siyu Yang,Zhenqi Lu
DOI: https://doi.org/10.3870/j.issn.1001-4152.2018.07.022
2018-01-01
Abstract:Objective To explore medication compliance and influencing factors at different stages of chemotherapy for orally taking capecitabine patients with colorectal cancer.Methods Totally 119 colorectal cancer patients orally taking capecitabine were investigated using Morisky Medication Adherence Scale 8(MMAS-8),quality of life questionnaire cancer30(EORTC QLQC30) and Beliefs about Medicines Questionnaire Specific(BMQ Specific) at the early stage (at the end of the first cycle),the middle stage (at the end of the 4 cycle) and the terminal stage (at the end of the 8 cycle) of medication.Results A total of 15 patients gave up taking medication,and 12 of them gave up at the first 3 cycles of chemotherapy.The scores of patients' medication compliance at the early stage,the middle stage and the terminal stage was 7.43±1.00,6.98±1.13 and 6.83±1.30 respectively,and there were significant differences among the scores at different stage (P<0.05).Regression analysis showed that,the predictors of medication compliance were loss of appetite,educational background and beliefs in medication at the early stage,fatigue and stoma at the middle stage,and living in Shanghai or other provinces and cities at the terminal stage.Conclusion Colorectal cancer patients undergoing oral chemotherapy are prone to give up medication in the first 3 cycles,and the patients who didn't give up totally have good medication compliance,which are influenced by different factors at different stage,thus nursing staff should formulate targeted nursing interventions.
What problem does this paper attempt to address?